New-onset atrial fibrillation is an independent predictor of in-hospital mortality in hospitalized heart failure patients: results of the EuroHeart Failure Survey
Open Access
- 31 May 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 29 (13) , 1618-1624
Abstract
The prognostic significance of atrial fibrillation (AF) in hospitalized patients with heart failure (HF) remains poorly understood. To evaluate in what way AF and its different modes of presentation affect the in-hospital mortality in patients admitted with HF. The EuroHeart Failure Survey was conducted to ascertain how hospitalized HF patients are managed in Europe. The survey enrolled patients over a 6-week period in 115 hospitals from 24 countries. For this analysis, patients were categorized into three groups according to the type of AF, previous AF (patients known to have had AF prior to admission), new-onset AF (no previous AF with AF diagnosed during hospitalization), and no AF (no previous AF and no AF during hospitalization). Clinical variables, duration of hospitalization, and in-hospital survival status were assessed and compared among groups. Of the 10 701 patients included in the survey; 6027 (57%) had no AF, 3673 (34%) had previous AF, and 1001 (9%) had new-onset AF. Patients with new-onset AF had a longer stay in the intensive care unit (ICU) when compared with previous AF and no AF patients (mean 2.6 ± 5.3, 1.2 ± 3.5, and 1.5 ± 4.1 days, respectively; P < 0.001). In-hospital mortality was higher among patients with new-onset AF when compared with previous AF or no AF patients (12, 7, and 7% respectively; P < 0.001). After adjusting for multiple clinical variables, new-onset AF (not previous AF) was an independent predictor of in-hospital mortality (odds ratio 1.53, 95% CI 1.1–2.0). In hospitalized patients with HF, new-onset AF is an independent predictor of in-hospital mortality and a longer ICU and hospital stay.Keywords
This publication has 17 references indexed in Scilit:
- Prevalence of Markers of Heart Failure in Patients with Atrial Fibrillation and the Effects of Ximelagatran Compared to Warfarin on the Incidence of Morbid and Fatal Events: A Report from the SPORTIF III and V TrialsEuropean Journal of Heart Failure, 2007
- Atrial Fibrillation and Risk of Clinical Events in Chronic Heart Failure With and Without Left Ventricular Systolic DysfunctionJACC, 2006
- Incident Atrial Fibrillation and Mortality in Older Adults with Heart FailureEuropean Journal of Heart Failure, 2005
- Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMETEuropean Heart Journal, 2005
- A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley studyThe American Journal of Medicine, 2002
- Prevalence of Diagnosed Atrial Fibrillation in AdultsJAMA, 2001
- Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failureEuropean Heart Journal, 2000
- Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trialsJACC, 1998
- Improving survival for patients with advanced heart failure: A study of 737 consecutive patientsJACC, 1995
- Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients.Circulation, 1991